T/ZGCIT 013-2024 Active Group standards

T/ZGCIT 013-2024 RNA-based biopharmaceutical product production technical specifications

T/ZGCIT 013-2024 RNA-based biopharmaceutical product production technical specifications

Publish Date: 2024-10-31 Implement Date: 2024-10-31 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/ZGCIT 013-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Comprehensive Pharmaceutical Science
Publish Date: 2024-10-31
Implement Date: 2024-10-31

Scope

Scope: This document specifies the terms and definitions, classification, detection, quality control, waste disposal, etc. of biomedical products based on RNA technology. This document is applicable to the production of biomedical products based on in vitro transcription technology and chemical synthesis technology; Main technical content: This document specifies the terms and definitions, classification, detection, quality control, waste disposal, etc. of biomedical products based on RNA technology.

Development Information

Related Standards

Contact Us